Editorial
Split Viewer
Blood Res 2016; 51(1):
Published online March 31, 2016
https://doi.org/10.5045/br.2016.51.1.1
© The Korean Society of Hematology
Application of next generation sequencing in the diagnosis and management of mast cell leukemia
Department of Laboratory Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
REFERENCES
- Heybeli, C. Mast cells, mastocytosis, and related disorders. N Engl J Med, 2015;373;1885.
- Chantorn, R, Shwayder, T. Death from mast cell leukemia: a young patient with longstanding cutaneous mastocytosis evolving into fatal mast cell leukemia. Pediatr Dermatol, 2012;29;605-609.
- Hermans, MA, Rietveld, MJ, van Laar, JA, et al. Systemic mastocytosis: A cohort study on clinical characteristics of 136 patients in a large tertiary centre. Eur J Intern Med[Epub ahead of print]
- Ustun, C, Smith, A, Cayci, Z, et al. Allogeneic hematopoietic cell transplantation in systemic mastocytosis: Is there a high risk for veno-occlusive disease. Eur J Haematol[Epub ahead of print]
- Arock, M, Sotlar, K, Akin, C, et al. KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis. Leukemia, 2015;29;1223-1232.
- Jawhar, M, Schwaab, J, Schnittger, S, et al. Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis. Leukemia, 2016;30;136-143.
- Youk, J, Koh, Y, Kim, J, et al. A scientific treatment approach for acute mast cell leukemia: Using a strategy based on next-generation sequencing data. Blood Res, 2016;51;17-22.
- Spector, MS, Iossifov, I, Kritharis, A, et al. Mast-cell leukemia exome sequencing reveals a mutation in the IgE mast-cell receptor β chain and KIT V654A. Leukemia, 2012;26;1422-1425.
- Georgin-Lavialle, S, Lhermitte, L, Dubreuil, P, Chandesris, MO, Hermine, O, Damaj, G. Mast cell leukemia. Blood, 2013;121;1285-1295.
PDF
Standard view
Export citation
Share Article
Editorial
Blood Res 2016; 51(1): 1-2
Published online March 31, 2016 https://doi.org/10.5045/br.2016.51.1.1
Copyright © The Korean Society of Hematology.
Application of next generation sequencing in the diagnosis and management of mast cell leukemia
Juwon Kim, M.D. Ph.D.
Department of Laboratory Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
- Heybeli, C. Mast cells, mastocytosis, and related disorders. N Engl J Med, 2015;373;1885.
- Chantorn, R, Shwayder, T. Death from mast cell leukemia: a young patient with longstanding cutaneous mastocytosis evolving into fatal mast cell leukemia. Pediatr Dermatol, 2012;29;605-609.
- Hermans, MA, Rietveld, MJ, van Laar, JA, et al. Systemic mastocytosis: A cohort study on clinical characteristics of 136 patients in a large tertiary centre. Eur J Intern Med[Epub ahead of print]
- Ustun, C, Smith, A, Cayci, Z, et al. Allogeneic hematopoietic cell transplantation in systemic mastocytosis: Is there a high risk for veno-occlusive disease. Eur J Haematol[Epub ahead of print]
- Arock, M, Sotlar, K, Akin, C, et al. KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis. Leukemia, 2015;29;1223-1232.
- Jawhar, M, Schwaab, J, Schnittger, S, et al. Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis. Leukemia, 2016;30;136-143.
- Youk, J, Koh, Y, Kim, J, et al. A scientific treatment approach for acute mast cell leukemia: Using a strategy based on next-generation sequencing data. Blood Res, 2016;51;17-22.
- Spector, MS, Iossifov, I, Kritharis, A, et al. Mast-cell leukemia exome sequencing reveals a mutation in the IgE mast-cell receptor β chain and KIT V654A. Leukemia, 2012;26;1422-1425.
- Georgin-Lavialle, S, Lhermitte, L, Dubreuil, P, Chandesris, MO, Hermine, O, Damaj, G. Mast cell leukemia. Blood, 2013;121;1285-1295.
Previous Article
